Dr. Scott Martin Vouri is quoted in Cardiology Today's October cover story on deprescribing CV medications.
The two-year, $800,000 grant is from the American Thrombosis Investigator Initiated Research Program.
Dr. Sabina Nduaguba The American Association for Cancer Research, or AACR, has awarded Sabina Nduaguba, Ph.D., a postdoctoral associate in the department of pharmaceutical outcomes and policy, a Minority Scholar in Cancer Research Award. Nduaguba evaluates racial/ethnic disparities related to cancer among people with HIV. “AACR has provided inspiration for formulating research…
Wei “Vivian” Wang, Ph.D., in the department of pharmaceutical outcomes and policy and Haesuk Park, Ph.D., an associate professor in the department, led the study.
Lo-Ciganic’s talk on Sept. 3 will focus on the application of advanced analytics in pharmaceutical outcomes research.
Lo-Ciganic received the award for her paper published in JAMA Network Open that reported on her and her co-authors’ investigation of five different machine learning approaches to predict opioid overdose.
Dr. Hincapie-Castillo has been appointed as a consultant to the FDA's Drug Safety and Risk Management Advisory Committee.
Researchers in the UF College of Pharmacy published the study in JAMA and used a commercial insurance database to examine the trends in the prescribing of preexposure prophylaxis for HIV prevention in the U.S.
Hartzema's study will evaluate a novel software tool developed to inform opioid prescribers of patient risks and therapy benefits.
Weihsuan “Jenny” Lo-Ciganic, Ph.D., M.S., M.S.Pharm., will lead a short course workshop on machine learning as part of the International Society for Pharmacoeconomics and Outcomes Research’s Virtual ISPOR 2020 Conference from 10 a.m. to 3 p.m. EST on Monday, July 27. Weishuan “Jenny” Lo-Ciganic, Ph.D., M.S., M.S.Pharm. Lo-Ciganic, as assistant professor in…